UNSPSC 51171651: Phenolphthalein glucuronide

This classification denotes an organic carcinogen with the molecular formula C26H22O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0S390I6642, chemically known as .beta.-d-glucopyranosiduronic acid, 4-(1,3-dihydro-1-(4-hydroxyphenyl)-3-oxo-1-isobenzofuranyl)phenyl, but more generally known as phenolphthalein glucuronide, which bears US NIH Compound Identifier 3032634.

European Medicines Agency schedules phenolphthalein glucuronide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09773MIG. Most nations, for tariff purposes, schedule phenolphthalein glucuronide under HS 29322910. SMILES: C1CCC2C(C1)C(=O)OC2(C3CCC(CC3)O)C4CCC(CC4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O.

UNSPSC 51171651 Phenolphthalein glucuronide, a Commodity code, shows minimal recent activity aligned with its chemical-compound scope. The three most recent state and local opportunities tagged under this code involve offender drug testing services, direct-to-manufacturer pharmacy procurement strategy, and generic pharmaceutical supply — work that does not center on phenolphthalein glucuronide as a procurement category. State and local buyers appear to use this code inconsistently or as a catch-all for broader pharmaceutical and laboratory testing services rather than as a narrowly defined chemical reagent line item.

The single opportunity with concrete scope detail is Collin County Community Supervision and Corrections Department's RFP 2026-327 for Offender Specimen Collection and Drug Testing Services, due July 23, 2026, which covers immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing, and electronic result reporting across two collection sites in Plano and McKinney, Texas, with an estimated contract value of $600,000 over two years and three optional one-year renewals. The Texas Health and Human Services Commission issued an exploratory RFI in April 2026 on direct-to-manufacturer pharmacy programs with no award value disclosed, and the Minnesota Department of Administration's Office of State Procurement (administering MMCAP) posted a multi-award RFP in January 2026 for generic pharmaceuticals and OTC products with a March 26, 2026 deadline. Geographic activity spans Texas and Minnesota. Given the mismatch between the code's nominal scope and the work actually being solicited, this code warrants monitoring only if your firm pursues laboratory testing services or pharmaceutical distribution — not for phenolphthalein glucuronide as a distinct product line.